Phlexglobal


THE COMPANY

Phlexglobal (Phlex) was a Private Equity (PE) backed technology and service provider selling solutions to global Pharmaceutical companies to support their clinical trials. I joined Phlex in 2018 to gain experience in a PE-backed company and to apply my skills in a new sector.


THE CHALLENGE

Phlex had recently been acquired by Vitruvian Partners. It operated in a growth market, but growth was being constrained. Despite its market‑leading technology and services, the business was struggling to execute and scale. 

The organisation had grown to over 400 employees across four countries, with revenues of £35m, but a founder‑led, command‑and‑control culture was increasingly inhibiting performance and growth. The challenge was how to adapt the culture to enable the next phase of growth, without losing the powerful aspects of the culture that got it this far.


THE SOLUTION

Vitruvian appointed a new executive team to lead the next phase of growth, and I joined as Chief People Officer. Over the following four years, we reshaped the organisation and changed the culture to support scale and improve productivity.

I led the work to establish a clear vision and set of values, empowered leaders and managers, clarified accountability and simplify the organisation design.


THE OUTCOME

The business matured into a more structured and effective organisation while retaining the entrepreneurial essence that underpinned its market leading position. Revenue per FTE increased along with employee engagement and retention. 

In 2022, Phlex was acquired by PharmaLex, backed by Auctus Capital. Six months later, PharmaLex was sold to AmerisourceBergen (now Cencora). These transactions represented my second and third successful exits.


Previous
Previous

Insights Ltd

Next
Next

Wireless Data Services (WDS)